Jun 30, 2017

United Therapeutics Q2 2017 Earnings Report

Total Revenue
$445M
Previous year: $413M
+7.8%
EPS
$4.37
Previous year: $4.55
-4.0%
Gross Profit
$426M
Previous year: $393M
+8.4%
Cash and Equivalents
$1.01B
Previous year: $838M
+20.1%
Free Cash Flow
$49.8M
Previous year: $241M
-79.3%
Total Assets
$2.69B
Previous year: $2.2B
+22.3%

United Therapeutics

United Therapeutics